LUX Infusion acquired by BioMatrix Specialty Infusion Pharmacy, a portfolio company of Frazier Healthcare Partners

Oct. 2025

Client: LUX Infusion is Alaska’s leading independent ambulatory infusion provider, offering safe, convenient, and cost-effective care for patients with acute and chronic conditions

Role: Edgemont Partners acted as exclusive financial advisor to LUX Infusion in its sale to BioMatrix Specialty Infusion Pharmacy, a portfolio company of Frazier Healthcare Partners. This is a transformative acquisition that expands BioMatrix’s national AIC network and establishes LUX Infusion as the unifying brand for its growing ambulatory infusion platform.

Location: Anchorage, AK

Sector: Pharmaceutical Supply Chain

Lead Banker: Patrick Bradley